Biomerica, Inc.
BMRA · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.9% | 1.4% | -71.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 9.4% | 11.3% | 8.4% | 15.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -89.2% | -110.7% | -128.7% | -20.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -93.6% | -110.4% | -133.7% | -24% |
| EPS Diluted | -2.16 | -0.36 | -0.5 | -0.36 |
| % Growth | -500% | 28% | -38.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |